Company intelligence / Profile preview
RenovoRx
Los Altos, California, United Statesrenovorx.com ↗
- Ownership
- Public · RNXT
- Employees
- ~10
- Development stage
- Other
01
Overview
RenovoRx’s lead product candidate, RenovoGem™, combines intra‐arterial gemcitabine with the proprietary FDA-cleared RenovoCath® device to deliver chemotherapy directly to solid tumors. In Phase I/II studies for unresectable locally advanced pancreatic cancer, median survival was reported at 27.9 months versus historical controls of 12–15 months. The pivotal Phase III TIGeR-PaC trial in LAPC patients continues enrollment and has Orphan Drug Designation from the FDA for both pancreatic and bile duct cancers[2][1].
- Therapeutic areas
- Oncology
- Modalities
- Drug-device combination (chemotherapy + device)Local drug delivery via intra-arterial infusion
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Imugene Limited – research collaboration to deliver oncolytic virus therapy for difficult-to-access tumors[3].
04
Financials
- Market cap
- $53.7M
- Total revenue
- $1.1M
- Enterprise value
- $43.5M
Beyond the preview
Go deeper on RenovoRx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RenovoRx.